Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-09
1986-03-04
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514343, 514351, 514357, 546193, 546281, 546300, 546330, 546332, A61K 31445, C07D21357, C07D21336
Patent
active
045741263
ABSTRACT:
This invention relates to 2-pyridine derivatives substituted in the 4-position with a dialkylamino- or piperidinyl- or pyrrolidinylalkyl group. The compounds have histamine H.sub.2 -antagonist activity.
REFERENCES:
patent: 4250316 (1981-02-01), Algieri et al.
patent: 4252819 (1981-02-01), Hirata et al.
patent: 4490533 (1984-12-01), Bolhofer et al.
Derwent Abstract 29067e (EP 49173), 4/7/82.
Derwent Abstract 20656d (Netherlands 8004967).
Derwent Abstract 55416e (EP 55179), 6/30/82.
Derwent Abstract 269k (EP 67436), 12/22/82.
Cooper David G.
Sach George S.
Foggio Richard D.
Keps Joan S.
Lourie Alan D.
Schwartz Richard A.
Smith Kline & French Laboratories Limited
LandOfFree
Pyridine derivatives histamine H.sub.2 -antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine derivatives histamine H.sub.2 -antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives histamine H.sub.2 -antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1594624